The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...
“Speed matters,” agrees Louise Binder, a lawyer, health advocate and health policy consultant with the Save Your Skin ...
CEO Will Bruey says people often get Varda wrong. The company isn't "in the space industry; we're in-space industry," he said ...
Recommendations from an all-party B.C. committee on democratic reform has reignited a longstanding conversation in the province about the possibility of proportional representation, a voting system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback